切换至 "中华医学电子期刊资源库"

中华实验和临床感染病杂志(电子版) ›› 2022, Vol. 16 ›› Issue (05) : 348 -353. doi: 10.3877/cma.j.issn.1674-1358.2022.05.010

短篇论著

人类免疫缺陷病毒感染合并鸟分枝杆菌复合群病临床特点
汤艳芬1, 赵雯1, 马成杰2, 刘刚1, 陈奇1, 刘菁1, 薛天娇1, 刘岩岩1, 陈融佥1, 王宇1,()   
  1. 1. 100015 北京,首都医科大学附属北京地坛医院呼吸科 感染病科 国家临床重点专科
    2. 100015 北京,首都医科大学附属北京地坛医院感染急诊
  • 收稿日期:2022-04-27 出版日期:2022-10-15
  • 通信作者: 王宇
  • 基金资助:
    "十三五"科技重大专项课题(No. 2017ZX10205502); 红丝带4号方治疗艾滋病免疫重建不良临床研究(No.首发2022-2-2176)

Clinical characteristics of Mycobacteria avium complex disease in patients with human immunodeficiency virus infection

Yanfen Tang1, Wen Zhao1, Chengjie Ma2, Gang Liu1, Qi Chen1, Jing Liu1, Tianjiao Xue1, Yanyan Liu1, Rongqian Chen1, Yu Wang1,()   

  1. 1. Department of Respiratory Medicine, National Clinical Key Department of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China
    2. Emergency of Infectious Diseases, National Clinical Key Department of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China
  • Received:2022-04-27 Published:2022-10-15
  • Corresponding author: Yu Wang
引用本文:

汤艳芬, 赵雯, 马成杰, 刘刚, 陈奇, 刘菁, 薛天娇, 刘岩岩, 陈融佥, 王宇. 人类免疫缺陷病毒感染合并鸟分枝杆菌复合群病临床特点[J]. 中华实验和临床感染病杂志(电子版), 2022, 16(05): 348-353.

Yanfen Tang, Wen Zhao, Chengjie Ma, Gang Liu, Qi Chen, Jing Liu, Tianjiao Xue, Yanyan Liu, Rongqian Chen, Yu Wang. Clinical characteristics of Mycobacteria avium complex disease in patients with human immunodeficiency virus infection[J]. Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition), 2022, 16(05): 348-353.

目的

探讨人类免疫缺陷病毒(HIV)感染合并鸟分枝杆菌复合群(MAC)病的临床特点,以提高其临床诊断和治疗水平。

方法

回顾性分析2011年1月至2021年7月于首都医科大学附属北京地坛医院住院经淋巴结穿刺活检组织学病理、肺泡灌洗液细胞学病理或二代测序技术(NGS)等确诊的HIV感染合并MAC病患者的临床资料,包括其临床表现、受累脏器、影像学表现、治疗以及预后等。年龄、白细胞计数、白蛋白、C-反应蛋白等呈正态分布,以± s表示;CD4+ T淋巴细胞水平、HIV RNA载量、抗反转录病毒治疗(ART)治疗时长等为非正态分布计量资料,以中位数(四分位数)[M(P25,P75)]表示。计数资料(性别、致病菌种和受累脏器等)以[例(%)]表示。

结果

入组HIV感染合并MAC病患者共13例,其中男性10例、女性3例,平均年龄(30.15 ± 6.5)岁。HIV合并MAC病患者CD4+ T淋巴细胞水平显著减低,CD4+ T淋巴细胞计数为[34(12.5,82)]个/μl。累及器官以淋巴结受累最为常见(61.5%、8/13),其次为肺(23.1%、3/13)。HIV感染合并MAC病最常见菌种为鸟分枝杆菌(76.9%、10/13),其次为胞内分枝杆菌(15.4%、2/13)。发热是HIV感染合并MAC病最常见的临床表现,占76.9%(10/13),其中90%(9/10)患者体温峰值超过39 ℃。HIV感染合并MAC肺病最常见的影像表现为斑片实变影,常伴纵膈淋巴结肿大。13例患者CD4+ T细胞计数为34(12.5,82)个/μl,53.8%(7/13)患者水平低于50个/μl。所有患者均根据菌种鉴定结果行经验性治疗,最常用的药物为大环内酯类(阿奇霉素或克拉霉素)[92.3%(12/13)]和乙胺丁醇[92.3%(12/13)]。

结论

在HIV感染人群中,MAC可累及全身多脏器,患者可出现高热、淋巴结受累,菌种主要鉴定为鸟分枝杆菌。应积极获取患者淋巴结、肺泡灌洗液等病理结果,尽早明确诊断,及时治疗。

Objective

To summarize the clinical characteristics of Mycobacterium avium (M. avium)complex (MAC) disease in human immunodeficiency virus (HIV)-infected patients, and to provide reference and evidence for clinical diagnosis and treatment of HIV-MAC.

Methods

A retrospective analysis was performed on histological pathology of lymph node biopsy, cytological pathology of alveolar lavage fluid or next generation sequencing technology (NGS) in Beijing Ditan Hospital, Capital Medical University from January 2011 to July 2021, including the clinical manifestations, affected organs, imaging findings, treatment and prognosis of patients with HIV infection and MAC. Age, white blood cell count, albumin and C-reactive protein were normal distribution, expressed as ± s. CD4+ T lymphocyte level, HIV load, antiretroviral treatment (ART) treatment duration were non-normal distribution measurement data, expressed as [M ( P25, P75 )]. The enumeration data (gender, pathogenic bacteria, involved organs, etc.) were expressed as [case (% )].

Results

Total of 13 patients were enrolled, among whom, 10 cases were male and 3 cases were female, with an average age of (30.15 ± 6.5) years old. The median CD4+ T count was [34 (12.5, 82)] cells/μl. Lymph node (61.5%, 8/13) involvement was the most common, followed by lung (23.1%, 3/13). There were 10 cases (76.9%, 10/13) infected with M. avium, 2 cases (15.4%, 2/13) with M. intercelleulare. Fever (76.9%, 10/13) was the most common clinical symptom of HIV infected patients associated with MAC. Most of the patients had a high fever. The peak temperature of 90% (9/10) cases was higher than 39 ℃. The frequent imaging findings of chest CT were patchy consolidation and lymphadenectasis. The CD4+ T cell count of 13 patients was [34 (12.5, 82 )] cells/μl, and the level of 53.8% (7/13) patients was lower than 50 cells/μl. All patients underwent empirical treatment according to the results of strain identification, and the most commonly used drugs were macrolides (azithromycin or clarithromycin) [92.3% (12/13)] and ethambutol [92.3% (12/13)].

Conclusions

The most common MAC species was M. avium in our series. The patients could have a high fever, lymph node involvement, and most were infected with M. avium. The pathological results of lymph nodes and alveolar lavage fluid should be actively obtained, with clear diagnosis as soon as possible and timely treatment.

表2 HIV/AIDS合并MAC病患者实验室指标
表1 HIV/AIDS合并MAC病患者临床特点
图1 HIV/AIDS合并MAC肺病患者胸部CT注:A:治疗前,右肺上叶可见片状实变影,内可见支气管充气征,周围可见多发磨玻璃密度影,纵隔内可见肿大淋巴结。B:抗MAC治疗2个月后,右肺病变明显吸收
[1]
Tortoli E. Impact of genotypic studies on mycobacterial taxonomy: the new mycobacteria of the 1990s[J]. Clin Microbiol Rev,2003,16(2):319-354.
[2]
王黎霞,成诗明,陈明亭, 等. 2010年全国第五次结核病流行病学抽样调查报告[J]. 中国防痨杂志,2012,34(8):485-508.
[3]
中华医学会结核病分会. 非结核分枝杆菌病诊断与治疗指南(2020年版)[J]. 中华结核和呼吸杂志,2020,43(11):918-946.
[4]
Pang Y, Tan Y, Chen J, et al. Diversity of nontuberculous mycobacteria in eastern and southern China: a cross-sectional study[J]. Eur Respir J,2017,49:1601429.
[5]
Nasiri MJ, Dabiri H, Darban-Sarokhalil D, et al. Prevalence of non-tuberculosis mycobacterial infections among tuberculosis suspects in Iran: systematic review and Meta-analysis[J]. PLoS One,2015,10(6):e129073.
[6]
Wang DM, Liao Y, Li QF, et al. Drug resistance and pathogenic spectrum of patients coinfected with nontuberculous mycobacteria and human-immunodeficiency virus in Chengdu, China[J]. Chin Med J (Engl),2019,132(11):1293-1297.
[7]
李太生,王福生,高福. 中国艾滋病诊疗指南(2018版)[J]. 中华临床感染病杂志,2018,11(6):411-432.
[8]
Daley CL, Iaccarino JM, Lange C, et al. Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline[J]. Eur Respir J,2020,56:2000535.
[9]
中华医学会热带病与寄生虫学分会艾滋病学组. 人类免疫缺陷病毒/艾滋病患者合并非结核分枝杆菌感染诊治专家共识[J]. 传染病信息,2019,32(6):481-489.
[10]
Lawn SD, Bekker LG, Miller RF. Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals[J]. Lancet Infect Dis,2005,5(6):361-373.
[11]
郭倩,朱召芹,钱雪琴, 等. 上海地区艾滋病患者合并非结核分枝杆菌感染菌种分布[J]. 中华传染病杂志,2019,37(2):93-96.
[12]
Fordham VRC, Arbeit RD, Tosteson AN, et al. The international epidemiology of disseminated Mycobacterium avium complex infection in AIDS. International MAC Study Group[J]. AIDS,1996,10(9):1025-1032.
[13]
朱明利,时代强,俞冠赟, 等. 艾滋病疑似合并结核病的多种特殊病原体检测及其意义[J]. 中华传染病杂志,2019,37(7):430-434.
[14]
Kitada S, Kobayashi K, Nishiuchi Y, et al. Serodiagnosis of pulmonary disease due to Mycobacterium avium complex proven by bronchial wash culture[J]. Chest,2010,138(1):236-237.
[15]
Buchacz K, Lau B, Jing Y, et al. Incidence of AIDS-defining opportunistic infections in a multicohort analysis of HIV-infected persons in the United States and Canada, 2000-2010[J]. J Infect Dis,2016,214(6):862-872.
[16]
Hill A L, Rosenbloom D, Nowak MA, et al. Insight into treatment of HIV infection from viral dynamics models[J]. Immunol Rev,2018,285(1):9-25.
[17]
Ashino Y, Guio H, Iwamoto A, et al. Serological response against Mycobacterium avium complex glycolipid antigens in patients with acquired immunodeficiency syndrome[J]. Microbiol Immunol,2008,52(1):36-39.
[18]
Heidary M, Nasiri MJ, Mirsaeidi M, et al. Mycobacterium avium complex infection in patients with human immunodeficiency virus: A systematic review and meta-analysis[J]. J Cell Physiol,2019,234(7):9994-10001.
[19]
Karakousis PC, Moore RD, Chaisson RE. Mycobacterium avium complex in patients with HIV infection in the era of highly active antiretroviral therapy[J]. Lancet Infect Dis,2004,4(9):557-565.
[20]
Lawn SD, Bekker LG, Miller RF. Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals[J]. Lancet Infect Dis,2005,5(6):361-373.
[21]
Smibert OC, Trubiano JA, Cross GB, et al. Short communication: Mycobacterium avium complex infection and immune reconstitution inflammatory syndrome remain a challenge in the era of effective antiretroviral therapy[J]. AIDS Res Hum Retroviruses, 2017,33(12):1202-1204.
[22]
Feysia SG, Hasan-Nejad M, Amini S, et al. Incidence, Clinical manifestation, treatment outcome, and drug susceptibility pattern of nontuberculous Mycobacteria in HIV patients in Tehran, Iran[J]. Ethiop J Health Sci,2020,30(1):75-84.
[23]
段鸿飞,王敬,初乃惠, 等. 鸟-胞内分枝杆菌复合菌组肺病与脓肿分枝杆菌肺病临床表现的对比观察[J]. 中华结核和呼吸杂志,2012,35(8):588-591.
[24]
Ryu YJ, Koh WJ, Daley CL. Diagnosis and treatment of nontuberculous mycobacterial lung disease: clinicians’ perspectives[J]. Tuberc Respir Dis (Seoul),2016,79(2):74-84.
[25]
Lan R, Yang C, Lan L, et al. Mycobacterium tuberculosis and non-tuberculous mycobacteria isolates from HIV-infected patients in Guangxi, China[J]. Int J Tuberc Lung Dis,2011,15(12):1669-1675.
[1] 吴茜, 邓力, 练士贤, 张华, 江颖, 张宏伟. 伴人类免疫缺陷病毒感染乳腺癌患者的临床病理特征与预后的相关性研究[J]. 中华乳腺病杂志(电子版), 2023, 17(03): 151-156.
[2] 张玉, 薛文瑞, 王鑫, 李旭瑜, 王旭东, 袁鹏飞, 梁雨润, 韩志兴, 张海建, 刘庆军, 纪世琪. 人类免疫缺陷病毒感染合并膀胱癌14例临床特点[J]. 中华实验和临床感染病杂志(电子版), 2023, 17(05): 354-358.
[3] 崔贵香, 丁晓燕, 褚盈晖, 孙代, 吴海燕, 陈京龙. 57例人类免疫缺陷病毒感染合并Burkkit淋巴瘤患者的临床分析[J]. 中华实验和临床感染病杂志(电子版), 2023, 17(02): 102-109.
[4] 袁瑞, 胡文佳, 桂希恩, 严亚军, 冯玲, 柯亨宁, 熊勇, 杨蓉蓉. 淋巴细胞精细分型检测在人类免疫缺陷病毒感染者/获得性免疫缺陷综合征患者中的应用[J]. 中华实验和临床感染病杂志(电子版), 2023, 17(02): 84-91.
[5] 李倩, 邓莉平, 陈果, 张忠威, 莫平征, 胡文佳, 陈良君, 张捷, 张永喜, 杨蓉蓉, 熊勇. 宏基因组二代测序在获得性免疫缺陷综合征合并中枢神经系统感染中的临床应用[J]. 中华实验和临床感染病杂志(电子版), 2023, 17(01): 24-31.
[6] 魏春波, 万钢, 许东梅, 赵兴云, 袁柳凤, 吴焱, 伦文辉. 60例人类免疫缺陷病毒感染者/获得性免疫缺陷综合征合并神经梅毒患者临床和实验室特征[J]. 中华实验和临床感染病杂志(电子版), 2022, 16(04): 254-260.
[7] 谭洁, 詹森林, 邓国防, 张培泽. 抗干扰素γ自身抗体综合征导致哥伦比亚分枝杆菌播散性感染一例[J]. 中华实验和临床感染病杂志(电子版), 2022, 16(03): 210-214.
[8] 杜娟, 宋波, 颜晓明, 牛佳鸣, 林元龙, 陈晓红, 李锦, 梁晗, 张铮, 李宇欧, 王福祥, 邵冰. 外周血单个核细胞内人类免疫缺陷病毒DNA和RNA定量对病毒转录活性的区分[J]. 中华实验和临床感染病杂志(电子版), 2022, 16(03): 165-171.
[9] 田飞, 高颂, 李铮, 王颖慧, 王媛媛. 1989至2020年北京市东城区1 076例人类免疫缺陷病毒感染者/获得性免疫缺陷综合征患者生存时间及影响因素[J]. 中华实验和临床感染病杂志(电子版), 2022, 16(02): 100-107.
[10] 张燕珍, 王锡携, 文小兰. 血清巨噬细胞迁移抑制因子对活动性肺结核分诊检测的意义[J]. 中华肺部疾病杂志(电子版), 2023, 16(02): 200-202.
[11] 洪青青, 姚超, 张新宝. 非结核分枝杆菌肺病患者流行病学临床特点及耐药情况分析[J]. 中华肺部疾病杂志(电子版), 2022, 15(04): 506-508.
[12] 赖宁, 庄泽钦, 钟典. 广州地区非结核分枝杆菌肺病微生物及临床特征分析[J]. 中华肺部疾病杂志(电子版), 2022, 15(03): 339-343.
[13] 陈众众, 闵凌峰, 刘家昌. 应用宏基因二代测序技术诊断胞内分枝杆菌型NTM肺病一例并文献复习[J]. 中华肺部疾病杂志(电子版), 2022, 15(03): 448-450.
[14] 王希岗, 张波, 李鸣, 高敏, 薛建新. 神经外科手术部位感染在HIV感染者与非HIV感染者中的临床差异[J]. 中华神经创伤外科电子杂志, 2023, 09(04): 228-233.
[15] 包训迪, 吴丹丹, 江跃, 梁锁, 王超, 王舒, 王庆. 非结核分枝杆菌鉴定方法和病原谱分析[J]. 中华临床医师杂志(电子版), 2022, 16(01): 38-42.
阅读次数
全文


摘要